On November 12, 2009, ARYx Therapeutics, Inc. reported its financial results for the three months ended September 30, 2009. A copy of the press release issued by ARYx on November 12, 2009 is furnished herewith as Exhibit 99.1 and is incorporated herein by reference.

The press release is furnished and shall not be deemed "filed" for purposes of
Section 18 of the Securities Exchange Act of 1934, as amended, or subject to the liabilities of that Section or Sections 11 and 12(a)(2) of the Securities Act of 1933, as amended. The information contained herein and in the accompanying exhibit shall not be incorporated by reference into any filing with the U.S. Securities and Exchange Commission made by ARYx, whether made before or after the date hereof, regardless of any general incorporation language in such filing.

(d) Exhibits

Exhibit Number                               Description
     99.1        Press release, dated November 12, 2009, entitled "ARYx Therapeutics
                 Reports Third Quarter 2009 Results."